Abilify and Dostinex drug interactions - a phase IV clinical study of FDA data
Summary:
Drug interactions are reported among people who take Abilify (aripiprazole) and Dostinex (cabergoline). Common drug interactions include weight increased among females and weight increased among males.
The phase IV clinical study analyzes what interactions people have when they take Abilify and Dostinex. It is created by eHealthMe based on reports of 24 people who take the same drugs from the FDA, and is updated regularly.
What is Abilify?
Abilify has active ingredients of aripiprazole. It is often used in depression. eHealthMe is studying from 101,454 Abilify users. Check the latest studies of Abilify.
What is Dostinex?
Dostinex has active ingredients of cabergoline. It is often used in prolactinoma. eHealthMe is studying from 3,064 Dostinex users. Check the latest studies of Dostinex.
24 people who take Abilify and Dostinex together, and have interactions are studied.

What are the common drug interactions of Abilify and Dostinex, by gender? *:
female:
- Weight increased
- Dyspnoea (difficult or laboured respiration)
- Heart rate increased
- Hunger
- Insomnia (sleeplessness)
- Obsessive-compulsive disorder (an anxiety disorder characterized by intrusive thoughts that produce uneasiness, apprehension, fear, or worry;)
- Periodic limb movement disorder
- Sleep paralysis (waking up and unable to move or speak)
- Snoring
- Anhedonia (inability to experience pleasure from activities usually found enjoyable)
male:
- Weight increased
- Arthralgia (joint pain)
- Encephalopathy (functioning of the brain is affected by some agent or condition)
- Haematemesis (vomiting of blood)
- Cardiac arrest
- Hyperthermia (body temperature greatly above normal)
- Hepatic cirrhosis (chronic liver disease characterized by replacement of liver tissue by fibrosis, scar tissue)
- Hypochromic anaemia (hypochromic anaemia is a generic term for any type of anaemia in which the red blood cells (erythrocytes) are paler than normal)
- Megakaryocytes (a bone marrow cell responsible for the production of blood thrombocyte)
- Blood prolactin increased
What are the common drug interactions of Abilify and Dostinex, by age (0-1 to 60+)? *:
0-1:
n/a
2-9:
n/a
10-19:
n/a
20-29:
- Blood cholesterol increased
- Diabetes mellitus (diabetes, caused by a deficiency of the pancreatic hormone insulin)
- Dizziness
- Extrapyramidal disorder (involuntary muscle spasms in the face and neck)
- Glycosuria (excretion of glucose into the urine)
- Hyperglycaemia (high blood sugar)
- Postural orthostatic tachycardia syndrome (abnormal increase in heart rate on becoming upright)
- Tremor (trembling or shaking movements in one or more parts of your body)
- Type 2 diabetes mellitus
- Neuropathy peripheral (surface nerve damage)
30-39:
- Weight increased
- Arthralgia (joint pain)
- Compulsive shopping
- Eating disorder
- Hospitalisation
- Nephrolithiasis (calculi in the kidneys)
- Blood prolactin increased
- Blood testosterone decreased
- Feeling hot
- Muscle cramp (painful sensation caused by muscle contraction)
40-49:
- Cardiac arrest
- Hyperthermia (body temperature greatly above normal)
- Hepatic cirrhosis (chronic liver disease characterized by replacement of liver tissue by fibrosis, scar tissue)
- Hypochromic anaemia (hypochromic anaemia is a generic term for any type of anaemia in which the red blood cells (erythrocytes) are paler than normal)
- Megakaryocytes (a bone marrow cell responsible for the production of blood thrombocyte)
- Blood glucose increased
50-59:
- Fatigue (feeling of tiredness)
- Insomnia (sleeplessness)
- Heart rate increased
- Hunger
- Merycism (a rare disease in which food is chewed, swallowed, and then returned to the mouth and chewed again)
- Muscle spasms (muscle contraction)
- Musculoskeletal pain (pain affects the bones, muscles, ligaments, tendons, and nerves)
- Obsessive-compulsive disorder (an anxiety disorder characterized by intrusive thoughts that produce uneasiness, apprehension, fear, or worry;)
- Periodic limb movement disorder
- Pseudodementia (severe form of depression that results from a progressive brain disorder in which cognitive changes mimic those of dementia)
60+:
n/a
What are the existing conditions these people have? *
- Stress And Anxiety: 9 people, 37.50%
- Pain: 8 people, 33.33%
- Sleep Disorder: 5 people, 20.83%
- Chest Pain: 5 people, 20.83%
- Bipolar Disorder (mood disorder): 5 people, 20.83%
- Nausea (feeling of having an urge to vomit): 4 people, 16.67%
- Insomnia (sleeplessness): 4 people, 16.67%
- High Blood Cholesterol: 4 people, 16.67%
- Psychotic Disorder: 3 people, 12.50%
- Schizoaffective Disorder (a mental disorder characterized by disordered thought): 3 people, 12.50%
* Approximation only. Some reports may have incomplete information.
Do you take Abilify and Dostinex?
- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously
Related studies:
Effectiveness of, side effects of, and alternative drugs to the 2 drugs:
Browse all drug interactions of Abilify and Dostinex:
a b c d e f g h i j k l m n o p q r s t u v w x y zSub-studies by gender and age:
Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Browse all side effects of Abilify:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all side effects of Dostinex:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Abilify and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Dostinex and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zRelated publications that referenced our studies
- Cetin, M., Celik, M., Cakici, M., Polat, M., & Suner, A, "Aripiprazole-Induced Hoarseness", Turk Psikiyatri Dergisi, 2018 Jan .
- Cetin M, Celik M, Cakici M, Polat M, Suner A, "Aripiprazole induced non-cardiogenic pulmonary edema: a case report", Turk Psikiyatri Dergisi, 2014 Dec .
- Gürbüz F, Ya?c?-Küpeli B, K?r Y, Yüksel B, Zorludemir S, Gürbüz BB, Küpeli S, "The first report of cabergoline-induced immune hemolytic anemia in an adolescent with prolactinoma", Journal of Pediatric Endocrinology and Metabolism, 2014 Jan .
- Harris YT, Harris AZ, "Cabergoline associated with first episode mania", Psychosomatics, 2012 Jan .
- Cetin, M., Celik, M., Cakici, M., Polat, M., & Suner, A, "Aripiprazole-Induced Hoarseness", Turk Psikiyatri Dergisi, 2018 Jan .
- Cetin M, Celik M, Cakici M, Polat M, Suner A, "Aripiprazole induced non-cardiogenic pulmonary edema: a case report", Turk Psikiyatri Dergisi, 2014 Dec .
- Gürbüz F, Ya?c?-Küpeli B, K?r Y, Yüksel B, Zorludemir S, Gürbüz BB, Küpeli S, "The first report of cabergoline-induced immune hemolytic anemia in an adolescent with prolactinoma", Journal of Pediatric Endocrinology and Metabolism, 2014 Jan .
- Harris YT, Harris AZ, "Cabergoline associated with first episode mania", Psychosomatics, 2012 Jan .
How the study uses the data?
The study uses data from the FDA. It is based on aripiprazole and cabergoline (the active ingredients of Abilify and Dostinex, respectively), and Abilify and Dostinex (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Drug interactions of Transderm Scop and Dexamethasone - now
- Drug interactions of Cyproheptadine Hydrochloride and Cefuroxime Axetil - 16 seconds ago
- Anger and Tinnitus - 22 seconds ago
- Drug interactions of Borage Oil and Hydrocortisone Acetate - 23 seconds ago
- Drug interactions of Midazolam and Sinemet - 28 seconds ago
- Could Mysoline cause Weakness? - 30 seconds ago
- Could Dostinex cause Metastases To Reproductive Organ? - 35 seconds ago
- Could Mycophenolate Mofetil cause Opsoclonus Myoclonus? - 37 seconds ago
- Could Oxycontin cause High Blood Pressure? - 41 seconds ago
- Drug interactions of Proleukin and Cyclophosphamide - 45 seconds ago